Regulations in the emerging market of nutraceuticals: From paradigms to practice

3^rd International Conference on Pharmaceutical Regulatory Affairs

October 21-23, 2013 DoubleTree by Hilton Hotel San Francisco Airport, CA, USA

Kerry Diaz

Scientific Tracks Abstracts: Pharmaceut Reg Affairs

Abstract :

It is increasingly recognized that most chronic diseases of concern today are multifactorial in origin. To combat such diseases and adverse health conditions, a treatment approach where medicines and nutraceutical complement each other may prove to be the most successful. An increasing number of products marketed as functional foods and dietary supplements such as probiotics, with their own health claim, are gaining immense popularity worldwide as consumers are adopting healthier lifestyles. This emerging market is considered to be positioned between traditional foods and medicines. This presentation will focus on aspects related to the regulatory framework and health claims of neutraceuticals. It will also address how the lack of international regulatory harmonization continues to pose constant marketing problems for the industry.

Biography :

Kerry Diaz is a Research and Regulatory Affairs Manager at Bio-K Plus International Inc., based in Montreal (Quebec), which is a recognized innovative biotechnology company, specialized in high quality and effective biotherapeutics. She has a Nursing degree and a Bachelor of Business Administration from HEC Montréal (affiliated business school of the University of Montreal). She has worked in the biopharmaceutical industry for over 12 years.